We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+31.27%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.91B
AUM Growth
+$590M
Cap. Flow
+$43.3M
Cap. Flow %
1.11%
Top 10 Hldgs %
41.55%
Holding
108
New
10
Increased
23
Reduced
13
Closed
15

Top Buys

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$49.2M
2
CRM icon
Salesforce
CRM
+$31.6M
3
RNAM
Avidity Biosciences
RNAM
+$30.3M
4
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$28.2M
5
FERG icon
Ferguson
FERG
+$26.4M

Top Sells

Rank Stock Value
1
ETNB
89bio
ETNB
+$60.4M
2
GEHC icon
GE HealthCare
GEHC
+$39.4M
3
DKS icon
Dick's Sporting Goods
DKS
+$28.8M
4
DDOG icon
Datadog
DDOG
+$24M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$16.7M

Sector Composition

Rank Sector Weight
1 Healthcare 51.02%
2 Technology 11.4%
3 Consumer Discretionary 5.04%
4 Financials 4.79%
5 Industrials 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.71T
$56.7M 1.45%
109,455
+10,627
+11% +$5.42M
PVLA
27
Palvella Therapeutics
PVLA
$2.27B
$51.6M 1.32%
822,400
+107,937
+15% +$4.81M
COF icon
28
Capital One
COF
$134B
$50.8M 1.3%
238,770
+44,610
+23% +$9.77M
DHR icon
29
Danaher
DHR
$144B
$50.7M 1.3%
255,800
+81,100
+46% +$16.1M
RCUS icon
30
Arcus Biosciences
RCUS
$3.64B
$50.2M 1.28%
3,688,858
– –
XBI icon
31
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$50.1M 1.28%
+500,000
New +$45M
FULC icon
32
Fulcrum Therapeutics
FULC
$297M
$49.5M 1.27%
5,381,000
+298,100
+6% +$2.16M
CMPX icon
33
Compass Therapeutics
CMPX
$387M
$49.4M 1.26%
14,101,159
+6,951,666
+97% +$22M
AMZN icon
34
Amazon
AMZN
$2.96T
$48M 1.23%
218,547
-39,078
-15% -$8.85M
TSLA icon
35
Tesla
TSLA
$1.3T
$40.6M 1.04%
91,252
-1,105
-1% -$383K
KDP icon
36
Keurig Dr Pepper
KDP
$40.8B
$40.1M 1.03%
+1,570,000
New +$49.2M
BSX icon
37
Boston Scientific
BSX
$71.5B
$34.5M 0.88%
353,561
– –
MSOS icon
38
AdvisorShares Pure US Cannabis ETF
MSOS
$880M
$34.3M 0.88%
+7,167,000
New +$28.2M
UNH icon
39
UnitedHealth
UNH
$370B
$33.2M 0.85%
96,220
+28,220
+42% +$8.53M
RNAM
40
DELISTED
Avidity Biosciences
RNAM
$32.7M 0.84%
+750,000
New +$30.3M
ERAS icon
41
Erasca
ERAS
$6.39B
$31.6M 0.81%
14,502,004
– –
INSM icon
42
Insmed
INSM
$28.6B
$31.4M 0.8%
217,783
-21,000
-9% -$2.57M
PROK icon
43
ProKidney
PROK
$337M
$29.9M 0.76%
12,341,266
– –
CRM icon
44
Salesforce
CRM
$158B
$29.7M 0.76%
+125,250
New +$31.6M
DKS icon
45
Dick's Sporting Goods
DKS
$18.7B
$28.5M 0.73%
128,290
-132,175
-51% -$28.8M
AURA icon
46
Aura Biosciences
AURA
$826M
$27M 0.69%
4,372,884
– –
KDP icon
47
CALL
Keurig Dr Pepper
KDP
$40.8B
$25.5M 0.65%
+1,000,000
New +$31.3M
GLUE icon
48
Monte Rosa Therapeutics
GLUE
$1.35B
$24.9M 0.64%
3,360,000
– –
JNJ icon
49
Johnson & Johnson
JNJ
$625B
$24.6M 0.63%
132,786
– –
ZURA icon
50
Zura Bio
ZURA
$567M
$23.7M 0.61%
5,472,891
+611,952
+13% +$1.1M
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Suvretta Capital Management held 108 positions worth $3.91B, up 18% from $3.32B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Suvretta Capital Management's Q3 2025 filing shows 10 new, 23 increased, 13 reduced and 15 closed positions. Its largest new stake was Keurig Dr Pepper: 1,570,000 shares worth $40.1M. The largest sale was 89bio, an estimated $60.4M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Suvretta Capital Management's largest Q3 2025 buy was Keurig Dr Pepper: 1,570,000 shares worth $40.1M.
  • Suvretta Capital Management added most to Ferguson in Q3 2025, an estimated $26.4M increase.
  • Suvretta Capital Management's biggest Q3 2025 reduction was 89bio, cutting an estimated $60.4M.
  • Suvretta Capital Management fully exited GE HealthCare in Q3 2025, selling an estimated $39.4M.
  • Suvretta Capital Management's ten largest holdings make up 42% of its $3.91B portfolio in Q3 2025.
  • Suvretta Capital Management opened 10 new positions and closed 15 in Q3 2025.
  • Suvretta Capital Management's portfolio value rose 18% quarter-over-quarter to $3.91B.

Based on Suvretta Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.